Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
12/2010
12/23/2010US20100322900 Treatment of multiple sclerosis with laquinimod
12/23/2010US20100322899 Methods of improving central nervous system functioning
12/23/2010US20100322856 Compositions and Methods for Inducing Angiogenesis
12/23/2010US20100322855 Bimodal ligands with macrocyclic and acyclic binding moieties, complexes and compositions thereof, and methods of using
12/23/2010DE102009025119A1 Herstellung und Verwendung antitumoraler, antibiotischer und insektizider Cyclodepsipeptide Production and use of antitumor, antimicrobial and insecticidal cyclodepsipeptides
12/23/2010CA2765876A1 Compositions and methods for treating amyotrophic lateral sclerosis
12/23/2010CA2765847A1 Prophylactic and/or therapeutic agent for dysmenorrhea
12/23/2010CA2765750A1 Novel phenylimidazole derivative as pde10a enzyme inhibitor
12/23/2010CA2765688A1 Protease variants
12/23/2010CA2765479A1 Treatment of inflammatory disorders, cardiovascular diseases and acute ischemic brain stroke with ozone
12/23/2010CA2765466A1 Diazahomoadamantane derivatives and methods of use thereof
12/23/2010CA2764124A1 Substituted isoquinoline derivative
12/23/2010CA2763960A1 Bicyclic and tricyclic compounds as kat ii inhibitors
12/23/2010CA2763551A1 Reversal of l-dopa-induced dyskinesia by neuronal nicotinic receptor ligands
12/23/2010CA2762304A1 1-(2-alkyl-2,3-dihydro-benzofuran-4-yl)-pyrrolidin-3-ylamine acyl compounds
12/23/2010CA2755467A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/22/2010EP2264173A2 Use of a double-stranded ribonucleic acid for targeted inhibition of the expression of a given target gene
12/22/2010EP2264172A1 Oligomeric compounds for the modulation of HIF-1alpha expression
12/22/2010EP2264062A1 Beta sheet inhibiting peptides for preventing and/or treating alzheimer's disease
12/22/2010EP2264052A2 Activatable recombinant neurotoxins
12/22/2010EP2264036A1 Amino-imidazolones for the inhibition of beta-secretase
12/22/2010EP2264035A1 Glycine B antagonists
12/22/2010EP2264029A1 1,3-dihydroisobenzofuran derivative
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264018A2 Thioflavin derivatives for use in the diagnosis of Alzheimer's disease
12/22/2010EP2263705A1 Therapeutic agent for nerve injury and method for treating nerve injury
12/22/2010EP2263695A2 Method and preparation for treating depressions
12/22/2010EP2263692A1 Anti-NGF antibodies and methods using same
12/22/2010EP2263678A2 Cladribine regimen for treating Multiple Sclerosis
12/22/2010EP2263675A2 Pharmaceutical compositions of a neuroactive steroid and uses thereof
12/22/2010EP2263673A1 Opioid formulations having extended controlled release
12/22/2010EP2263672A1 Novel pharmaceutically acceptable salts of 4-(1H-imidazol-4-ylmethyl)pyridine and their therapeutical uses
12/22/2010EP2263665A1 New compositions for treating CMT and related disorders
12/22/2010EP2263658A1 Controlled release hydrocodone formulations
12/22/2010EP2263652A1 Aerosols comprising nanoparticle drugs
12/22/2010EP2263453A1 Transgenic animal model of neurodegenerative disorders
12/22/2010EP2262811A1 1,2,4-triazolo[4,3-c]pyrimidin-3-one and pyrazolo [4,3-e]-1,2,4-triazolo [4,3-c]pyrimidin-3-one compounds for use as adenosine a2a receptor antagonists
12/22/2010EP2262805A1 Polysubstituted derivatives of 2-heteroaryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262804A1 Polysubstituted derivatives of 6-heteroaryl-imidazo[l,2- a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262803A1 Polysubstituted derivatives of 2-aryl-6-phenyl-imidazo[l,2-a] pyridines, and preparation and therapeutic use thereof
12/22/2010EP2262797A1 Insulin-regulated aminopeptidase (irap) inhibitors and uses thereof
12/22/2010EP2262795A1 Muscarinic receptor agonists, compositions, methods of treatment thereof, and processes for preparation thereof
12/22/2010EP2262789A1 2-aminoquinolines
12/22/2010EP2262781A1 Novel 1,2,3-triazole derivatives useful as modulators of nicotinic acetylcholine receptors
12/22/2010EP2262774A2 2-aminoquinolines
12/22/2010EP2262773A1 2-aminoquinoline derivatives
12/22/2010EP2262769A1 Polysubstituted 2-aryl-6-phenyl-imidazo[1,2-a]pyridine derivatives, and preparation and therapeutic use thereof
12/22/2010EP2262764A2 Novel n-benzylamide substituted derivatives of 2-(acylamido)acetic acid and 2-(acylamido)propionic acids: potent neurological agents
12/22/2010EP2262527A2 Method for achieving desired glial growth factor 2 plasma levels
12/22/2010EP2262526A1 Stable amyloid beta monomers and oligomers
12/22/2010EP2262525A1 Apoaequorin-containing compositions and methods of using same
12/22/2010EP2262512A1 Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries
12/22/2010EP2262502A1 Compositions and methods for alleviating depression or improving cognition
12/22/2010EP2262498A2 Pyrimidines and pyridines useful as inhibitors of protein kinases
12/22/2010EP2262495A2 Pharmaceutical composition comprising racetam and carnitine and process for its preparation
12/22/2010EP2094684B1 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin 2-ones as cb1 receptor modulators
12/22/2010EP2061774B1 Arylpiperazine derivatives and uses thereof
12/22/2010EP2004688B1 Improved protofibril selective antibodies and the use thereof
12/22/2010EP1943230B1 Compounds which have activity at m1 receptor and their uses in medicine
12/22/2010EP1915345B1 Fluoro substituted 2-oxo azepan derivatives
12/22/2010EP1845957B1 Method for producing a drug extract that contains hydroxystilbenes
12/22/2010EP1839653B9 Therapeutic agent for sensory disorders
12/22/2010EP1804800B1 Use of 4-(4-methylpiperazin-1-ylmethyl)-n-4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl¨-benzamide to inhibit the tyrosine kinase receptor c-fms
12/22/2010EP1651232B1 Compounds for inflammation and immune-related uses
12/22/2010EP1453805B1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
12/22/2010EP1392696B1 Polymorph forms of n-(2,3-dimethyl-5,6,7,8-tetrahydrofuro 2,3-b quinolin-4-yl)-2-(2- oxopyrrolidin -1 -yl)acetamide
12/22/2010EP1390037B1 Use of glucocorticoid receptor-specific antagonists for the treatment of delirium
12/22/2010EP1368013B1 Cyclohexenone derivative for treating diabetic neuropathy
12/22/2010EP1135496B1 Ucp5
12/22/2010CN1914208B Substituted 8'-pyri(mi)dinyl-dihydrospiro-[cycloalklymine]-pyrimido[1,2a]pyrimidin-6-one derivatives
12/22/2010CN1824075B Medicinal composition for treating hemicrania and its application
12/22/2010CN1812973B Indazole compounds useful as protein kinase inhibitors
12/22/2010CN1662242B Pharmaceutical compositions for the treatment of diseases related to neurotrophines
12/22/2010CN1547477B Derivatives of partially desulphated glycosaminoglycans as heparanase inhibitors, endowed with antiangiogenic activity and devoid of anticoagulating effect
12/22/2010CN101925607A Crystalline cinnamide compounds or salts thereof
12/22/2010CN101925605A Tricyclic triazolic compounds
12/22/2010CN101925603A Modulators of cystic fibrosis transmembrane conductance regulator
12/22/2010CN101925599A Biaryl substituted azabicyclic alkane derivatives as nicotinic acetylcholine receptor activity modulators
12/22/2010CN101925590A Aldh-2 inhibitors in treatment of addiction
12/22/2010CN101925578A 6-substituted-thio-2-amino-quinoline derivatives useful as inhibitors of ss-secretase (BACE)
12/22/2010CN101925576A Kappa selective opioid receptor antagonist
12/22/2010CN101925355A Fentanyl-containing patch for external use
12/22/2010CN101925352A Compositions comprising nicotinic agonists and methods of using same
12/22/2010CN101921772A Human antibodies that bind human IL-12 and methods for producing
12/22/2010CN101921769A Recombinant adenovirus, preparation method and application thereof
12/22/2010CN101921314A Brain-targeting neurotrophic factor fusion polypeptide for preventing and treating Alzheimer's disease
12/22/2010CN101921279A Spirocyclic heterocyclic derivatives and methods of their use
12/22/2010CN101921270A Mangiferin berberine salt, preparation method thereof and use thereof
12/22/2010CN101921267A Beta -lactamyl vasopressin Vla antagonists
12/22/2010CN101921266A 3,4,6-triaryl-[1,3]-oxazine compound as well as preparation method and application thereof
12/22/2010CN101921256A Diphenyl pyrone amide derivative and preparation method and application thereof
12/22/2010CN101921229A Synthesis method of stepholidine or derivative optical isomer thereof and intermediate thereof
12/22/2010CN101920008A Preparation containing Abeta 40 polypeptide and aluminum adjuvant and method for purifying Abeta 40 polypeptide
12/22/2010CN101919995A Medicine for curing intermingled phlegm and blood stasis type epilepsy and preparation method thereof
12/22/2010CN101919992A Preparation utilizing Chinese herbal medicines to reduce human body platelet filtration serum dirt and prevent and cure cerebral hemorrhage
12/22/2010CN101919982A Medicinal combination for relieving alcoholism and protecting liver and functional chewing gum prepared therefrom
12/22/2010CN101919978A Traditional Chinese medicine composition, preparation method and application thereof
12/22/2010CN101919968A New application of traditional Chinese medicine composition for treating headache
12/22/2010CN101919964A Traditional Chinese medical preparation for treating deadlimb
12/22/2010CN101919962A Medicine for curing insomnia and preparation method thereof
1 ... 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 ... 1833